Tyrosyl-tRNA synthetase has a noncanonical function in actin bundling

Nat Commun. 2023 Mar 8;14(1):999. doi: 10.1038/s41467-023-35908-3.

Abstract

Dominant mutations in tyrosyl-tRNA synthetase (YARS1) and six other tRNA ligases cause Charcot-Marie-Tooth peripheral neuropathy (CMT). Loss of aminoacylation is not required for their pathogenicity, suggesting a gain-of-function disease mechanism. By an unbiased genetic screen in Drosophila, we link YARS1 dysfunction to actin cytoskeleton organization. Biochemical studies uncover yet unknown actin-bundling property of YARS1 to be enhanced by a CMT mutation, leading to actin disorganization in the Drosophila nervous system, human SH-SY5Y neuroblastoma cells, and patient-derived fibroblasts. Genetic modulation of F-actin organization improves hallmark electrophysiological and morphological features in neurons of flies expressing CMT-causing YARS1 mutations. Similar beneficial effects are observed in flies expressing a neuropathy-causing glycyl-tRNA synthetase. Hence, in this work, we show that YARS1 is an evolutionary-conserved F-actin organizer which links the actin cytoskeleton to tRNA-synthetase-induced neurodegeneration.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins* / metabolism
  • Animals
  • Cell Line, Tumor
  • Charcot-Marie-Tooth Disease / genetics
  • Drosophila / genetics
  • Glycine-tRNA Ligase / genetics
  • Humans
  • Mutation
  • RNA, Transfer
  • Tyrosine-tRNA Ligase* / genetics
  • Tyrosine-tRNA Ligase* / metabolism

Substances

  • Actins
  • Glycine-tRNA Ligase
  • RNA, Transfer
  • Tyrosine-tRNA Ligase